Two GPs who love menopause medicine walk through how they actually run a menopause consult in real life from the first question they ask to the moment they decide whether or not to start MHT
Dr Jane Elliott AM and Prof Rod Baber AM explore practical non-hormonal approaches to managing vasomotor menopausal symptoms, including where fezolinetant sits in care for women who cannot or prefer not to use MHT
Dr Georgia Rigas and Dr Nadia Tejani joins Dr Angela Kwong to unpack perimenopausal weight gain, cardiometabolic risk, and the evolving roles of MHT and GLP‑1s in midlife care.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.